Blood levels of inflammatory and destructive biomarkers in coronary atherosclerosis of different severity

Bulletin of Experimental Biology and Medicine

Volumn 149, Issue 5, 2010, Pages 587-590

  Ragino, Yu I ^a,b   Chernjavski, A M ^a   Polonskaja, Ya V ^a   Tchimbal, S Yu ^a   Redjkin, D A ^a   Semaeva, E V ^a   Kashtanova, E V ^a   Voevoda, M I ^a  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^b MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

Author keywords

Biomarkers of atherosclerotic plaque instability; Coronary atherosclerosis; Highly sensitive C reactive protein; Metalloproteinases

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; DIET RESTRICTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; RIGHT CORONARY ARTERY;

ACUTE CORONARY SYNDROME; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC;

EID: 79951593813     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-010-0999-8     Document Type: Article

References (15)

1. Yu. I. Ragino, A. M. Cherjyavski, Ya. V. Polonskaja, et al., Byull. Eksp. Biol. Med., 144, No. 11, 500-503 (2007).
2. Yu. I. Ragino, A. M. Chernjavski, Ya. V. Polonskaja, et al., Kardiologiya, No. 9, 62-67 (2007).
3. E. J. Armstrong, D. A. Morrow, and M. S. Sabatine, Circulation, 113, No. 6, e72-75 (2006).
4. E. J. Armstrong, D. A. Morrow, and M. S. Sabatine,Circulation, Ibid., 113, No. 7, e152-155 (2006).
5. E. J. Armstrong, D. A. Morrow, and M. S. Sabatine, Circulation, Ibid., 113, No. 9, e382-385 (2006).
6. M. Asakura, Y. Ueda, O. Yamaguchi, et al., J. Am. Coll Cardiol., 37, No. 5, 1284-1288 (2001).
7. J. C. Fruchart, Handbook of Dyslipidemia and Atherosclerosis. France, University of Lille (2003), Pt. 1. pp. 1-65.
8. J. A. Goldstein, D. Demetriou, C. L. Grines, et al., N. Engl. J. Med., 343, No. 13, 915-922 (2000).
9. D. G. Katritsis, J. Pantos, and E. Efstathopoulos, Coron. Artery Dis., 18, No. 3, 229-237 (2007).
10. M. Naghavi, E. Falk, H. S. Hecht, et al., Am. J. Cardiol., 98, No. 2A, 2H-15H (2006).
11. M. Naghavi, P. Libby, E. Falk, et al., Circulation, 108, No. 14, 1664-1672 (2003).
12. P. J. Scanlon, D. P. Faxon, A. M. Audet, et al., J. Am. Coll Cardiol., 33, No. 6, 1756-1824 (1999).
13. P. K. Shah, High-Risk Atherosclerotic Plaques: Mechanisms, Imaging, Models, and Therapy. Ed. L. M. Khachigian, New York (2005), pp. 1-19.
14. P. K. Shah and B. Sharifi , Biochemistry of Atherosclerosis, Ed. S. K. Cheema, New York (2006), pp. 455-563.
15. R. Waksman and P. W. Seruys, Handbook of the Vulnerable Plaque. London (2004), pp. 1-48